389 results on '"Zannoni GF"'
Search Results
2. 299 Precision oncology in surgery: patient selection for operable recurrent hepatic ovarian cancer
3. 21 Prevalence of BRCA1/2 mutation and alterations of homologous recombination deficiency (HRD) in uterine leiomyosarcoma: a retrospective, monocentric study
4. 17 Standard ultrastaging (SU) compared to one-step nucleic acid amplification (OSNA) for sentinel lymph nodemetastasis detection in endometrial cancer patients: a retrospective large cohort comparison
5. Imaging in gynecological disease: clinical and ultrasound characteristics of endometrioid ovarian cancer
6. Ligneous cervicitis: a rare benign condition that mimics cervical adenocarcinoma. A report of two cases
7. Neoadjuvant Radio-Chemotherapy for Uterine Cervix Carcinoma: A Regression Grading System as a New Prognostic Parameter
8. Clinical, pathological and molecular prognostic factors for Non-Endometrioid (Type II) Endometrial Carcinoma
9. Nasosinusal melanoma a rare (?) disease and potential diagnostic pitfall. 12 years of experience
10. Survivin Expression in Cervix Carcinoma Correlates with Residual Disease after Neoadjuvant Radio-Chemotherapy
11. SECONDARY MALIGNANCY TO THE UTERINE CERVIX: TOO UNCOMMON TO BE CONSIDERED? THE ROLE OF THE PATHOLOGIST
12. BRAF Mutation (V600E) in Papillary Carcinoma Identified on LBC-Processed Thyroid Aspiration Biopsies
13. Benign cystic peritoneal mesothelioma incorrectly diagnosed as an ovarian borderline mucinous tumor of intestinal type of transvaginal preoperative ultrasound evaluation
14. Buschke-Lowenstein tumour in a pregnant and immunosupressed patient: are both concomitant increasing risk factors?'
15. Ectopic thyroid tissue misdiagnosed as metastatic carcinoma: Case report with immunohistochemical study
16. Does clear cell carcinoma really belongs to type I ovarian carcinoma?
17. Clinical-pathological and molecular features of poorly differentiated endometrioid carcinomas (G3 FIGO) in comparison with well differentiated endometrioid carcinoma ( G1 and G2 FIGO) and non-endometrioid carcinoma
18. Metastases to uterine cervix. A rare disease and potential diagnostic pitfall
19. Cytoplasmic expression of Estrogen Receptor Beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in ederly women
20. Endoscopic surgery in ovarian endometriosis: histopathologic observations on the loss of follicular tissue during treatment
21. Liquid-Based Cytology Improves the Identification of Malignant Tumors in Thyroid Fine-Needle Biopsies
22. Assessment of myometrial invasion in endometrial cancer by transvaginal sonography and frozen section
23. Clinical performance of HPV E6 and E7 mRNA testing for high grade lesions of the cervix
24. Histopathological evaluation of post radio-chemotherapy response on hysterectomy specimens for cervical carcinoma
25. Balance between Hepatocyte Growth Factor(HGF) and Tranforming Growth Factor (TGF-Beta) in renal biopsies of patiens with lupus nephritis
26. Hepatocyte Growth Factor(HGF)/Tranforming Growth Factor (TGF-Beta) balance in renal biopsies and clinical outcome in patiens with lupus nephritis treated with cyclophosphamide
27. Sonographic features of decidualized ovarian endometriosis suspicious for malignancy
28. Asymptomatic intrathyroidal parathyroid adenoma - Report of a case with a cytologic differential diagnosis including thyroid neoplasms
29. Oligodendroglioma arising within a mature cystic ovarian teratoma: case report and review of the literature
30. Fine needle aspiration of a warthin-like thyroid tumor - Report of a case with differential diagnostic criteria vs. other lymphocyte-rich thyroid lesions
31. Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland.
32. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
33. Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison
34. Clear cell endometrial carcinoma and the TCGA classification
35. Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.
36. Endometrial cancer and 2023 FIGO staging system: Not too soon, but maybe too much?
37. Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants.
38. Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia.
39. Morphological and immunohistochemical evaluation in distinguishing post-radiotherapy serous-like endometrial change (PoRSEC) and serous endometrial intraepithelial carcinoma (SEIC).
40. A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial Lesion UltrasouNd And mRi study.
41. Atypical glandular cells and predictive features of malignancy in Pap smears: A retrospective monocentric study.
42. Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
43. Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis.
44. Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?
45. The HER2-low revolution in gynecological oncology: could it be a realistic emerging challenge?
46. Microscopic sex cord-stromal proliferations in extraovarian heterotopic sites: Report of a rare case and review of the literature.
47. The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations.
48. The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.
49. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
50. Ovarian endometrioid carcinoma with a sex cord-like pattern: a morphological, immunohistochemical, and molecular analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.